Precision BioSciences Inc
NASDAQ:DTIL

Watchlist Manager
Precision BioSciences Inc Logo
Precision BioSciences Inc
NASDAQ:DTIL
Watchlist
Price: 6.86 USD -5.25% Market Closed
Market Cap: 52.6m USD
Have any thoughts about
Precision BioSciences Inc?
Write Note

Intrinsic Value

DTIL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one DTIL stock under the Base Case scenario is 12.31 USD. Compared to the current market price of 6.86 USD, Precision BioSciences Inc is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DTIL Intrinsic Value
12.31 USD
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Precision BioSciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DTIL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DTIL?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Precision BioSciences Inc

Provide an overview of the primary business activities
of Precision BioSciences Inc.

What unique competitive advantages
does Precision BioSciences Inc hold over its rivals?

What risks and challenges
does Precision BioSciences Inc face in the near future?

Has there been any significant insider trading activity
in Precision BioSciences Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Precision BioSciences Inc.

Provide P/S
for Precision BioSciences Inc.

Provide P/E
for Precision BioSciences Inc.

Provide P/OCF
for Precision BioSciences Inc.

Provide P/FCFE
for Precision BioSciences Inc.

Provide P/B
for Precision BioSciences Inc.

Provide EV/S
for Precision BioSciences Inc.

Provide EV/GP
for Precision BioSciences Inc.

Provide EV/EBITDA
for Precision BioSciences Inc.

Provide EV/EBIT
for Precision BioSciences Inc.

Provide EV/OCF
for Precision BioSciences Inc.

Provide EV/FCFF
for Precision BioSciences Inc.

Provide EV/IC
for Precision BioSciences Inc.

Show me price targets
for Precision BioSciences Inc made by professional analysts.

What are the Revenue projections
for Precision BioSciences Inc?

How accurate were the past Revenue estimates
for Precision BioSciences Inc?

What are the Net Income projections
for Precision BioSciences Inc?

How accurate were the past Net Income estimates
for Precision BioSciences Inc?

What are the EPS projections
for Precision BioSciences Inc?

How accurate were the past EPS estimates
for Precision BioSciences Inc?

What are the EBIT projections
for Precision BioSciences Inc?

How accurate were the past EBIT estimates
for Precision BioSciences Inc?

Compare the revenue forecasts
for Precision BioSciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Precision BioSciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Precision BioSciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Precision BioSciences Inc compared to its peers.

Compare the P/E ratios
of Precision BioSciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Precision BioSciences Inc with its peers.

Analyze the financial leverage
of Precision BioSciences Inc compared to its main competitors.

Show all profitability ratios
for Precision BioSciences Inc.

Provide ROE
for Precision BioSciences Inc.

Provide ROA
for Precision BioSciences Inc.

Provide ROIC
for Precision BioSciences Inc.

Provide ROCE
for Precision BioSciences Inc.

Provide Gross Margin
for Precision BioSciences Inc.

Provide Operating Margin
for Precision BioSciences Inc.

Provide Net Margin
for Precision BioSciences Inc.

Provide FCF Margin
for Precision BioSciences Inc.

Show all solvency ratios
for Precision BioSciences Inc.

Provide D/E Ratio
for Precision BioSciences Inc.

Provide D/A Ratio
for Precision BioSciences Inc.

Provide Interest Coverage Ratio
for Precision BioSciences Inc.

Provide Altman Z-Score Ratio
for Precision BioSciences Inc.

Provide Quick Ratio
for Precision BioSciences Inc.

Provide Current Ratio
for Precision BioSciences Inc.

Provide Cash Ratio
for Precision BioSciences Inc.

What is the historical Revenue growth
over the last 5 years for Precision BioSciences Inc?

What is the historical Net Income growth
over the last 5 years for Precision BioSciences Inc?

What is the current Free Cash Flow
of Precision BioSciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Precision BioSciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Precision BioSciences Inc

Current Assets 110.5m
Cash & Short-Term Investments 101.2m
Receivables 1.5m
Other Current Assets 7.8m
Non-Current Assets 42.7m
Long-Term Investments 3.2m
PP&E 11m
Intangibles 388k
Other Non-Current Assets 28.2m
Current Liabilities 12m
Accounts Payable 958k
Accrued Liabilities 8.2m
Other Current Liabilities 2.9m
Non-Current Liabilities 76.4m
Long-Term Debt 22.3m
Other Non-Current Liabilities 54.1m
Efficiency

Earnings Waterfall
Precision BioSciences Inc

Revenue
75.1m USD
Operating Expenses
-91.3m USD
Operating Income
-16.2m USD
Other Expenses
24.8m USD
Net Income
8.6m USD

Free Cash Flow Analysis
Precision BioSciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DTIL Profitability Score
Profitability Due Diligence

Precision BioSciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Exceptional 1-Year Revenue Growth
Positive ROE
24/100
Profitability
Score

Precision BioSciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

DTIL Solvency Score
Solvency Due Diligence

Precision BioSciences Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
49/100
Solvency
Score

Precision BioSciences Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DTIL Price Targets Summary
Precision BioSciences Inc

Wall Street analysts forecast DTIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DTIL is 34.27 USD with a low forecast of 19.19 USD and a high forecast of 63 USD.

Lowest
Price Target
19.19 USD
180% Upside
Average
Price Target
34.27 USD
400% Upside
Highest
Price Target
63 USD
818% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DTIL?

Click here to dive deeper.

Dividends

Precision BioSciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DTIL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DTIL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Precision BioSciences Inc Logo
Precision BioSciences Inc

Country

United States of America

Industry

Biotechnology

Market Cap

51.3m USD

Dividend Yield

0%

Description

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. The company is headquartered in Durham, North Carolina and currently employs 198 full-time employees. The company went IPO on 2019-03-28. The company is developing ex vivo allogeneic CAR T immunotherapies and in vivo therapies for genetic and infectious diseases with the application of its owned ARCUS genome editing platform. The firm's ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make specific cuts and DNA insertions in cellular DNA. Its Ex vivo Allogeneic CAR T Immunotherapy pipeline offers programs, including PBCAR0191, PBCAR19B, PBCAR269A and CD19 Combination with Foralumab. Its in-vivo Gene Correction pipeline offers three preclinical programs, including PBGENE-PCSK9, PBGENE-PH1 and PBGENE-HBV. Its subsidiaries include Precision PlantSciences, Inc. and Precision BioSciences UK Limited.

Contact

NORTH CAROLINA
Durham
302 E Pettigrew St Ste A100
+19193145512.0
precisionbiosciences.com

IPO

2019-03-28

Employees

198

Officers

President, CEO & Director
Mr. Michael Amoroso
CFO & Principal Accounting Officer
Mr. John Alexander Kelly R.Ph.
Co-Founder & Chief Research Officer
Dr. Jefferson J. Smith Ph.D.
Chief of Staff to CEO & Head of Investor Relations
Mr. Naresh Tanna
General Counsel & Secretary
Mr. Dario Scimeca
Vice President of Quality & Compliance
Mr. Bruce Stevens
Show More
Senior Director of Corporate Communications
Maurissa Messier
Chief People Officer
Ms. Juli Blanche
Head of Manufacturing
Mr. Garrett Gincley
Chief Business Officer
Ms. Cindy Atwell
Show Less

See Also

Discover More
What is the Intrinsic Value of one DTIL stock?

The intrinsic value of one DTIL stock under the Base Case scenario is 12.31 USD.

Is DTIL stock undervalued or overvalued?

Compared to the current market price of 6.86 USD, Precision BioSciences Inc is Undervalued by 44%.

Back to Top